Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Language
Year range
1.
Clinics ; 67(12): 1463-1468, Dec. 2012. ilus
Article in English | LILACS | ID: lil-660476

ABSTRACT

OBJECTIVE: Volume replacement in septic patients improves hemodynamic stability. This effect can reduce the inflammatory response. The objective of this study was to evaluate the effect of 7.5% hypertonic saline solution versus 0.9% normal saline solution for volume replacement during an inflammatory response in endotoxemic rats. METHODS: We measured cytokines (serum and gut), nitrite, and lipid peroxidation (TBARS) as indicators of oxidative stress in the gut. Rats were divided into four groups: control group (C) that did not receive lipopolysaccharide; lipopolysaccharide injection without treatment (LPS); lipopolysaccharide injection with saline treatment (LPS +S); and lipopolysaccharide injection with hypertonic saline treatment (LPS +H). Serum and intestine were collected. Measurements were taken at 1.5, 8, and 24 h after lipopolysaccharide administration. RESULTS: Of the four groups, the LPS +H group had the highest survival rate. Hypertonic saline solution treatment led to lower levels of IL-6, IL-10, nitric oxide, and thiobarbituric acid reactive substances compared to 0.9% normal saline. In addition, hypertonic saline treatment resulted in a lower mortality compared to 0.9% normal saline treatment in endotoxemic rats. Volume replacement reduced levels of inflammatory mediators in the plasma and gut. CONCLUSION: Hypertonic saline treatment reduced mortality and lowered levels of inflammatory mediators in endotoxemic rats. Hypertonic saline also has the advantage of requiring less volume replacement.


Subject(s)
Animals , Male , Rats , Endotoxemia/metabolism , Interleukins/metabolism , Lipid Peroxidation/drug effects , Nitrites/metabolism , Oxidative Stress , Saline Solution, Hypertonic/pharmacology , Systemic Inflammatory Response Syndrome/therapy , Disease Models, Animal , Endotoxemia/chemically induced , Hemodynamics/drug effects , Inflammation Mediators/blood , Inflammatory Bowel Diseases/metabolism , Inflammatory Bowel Diseases/pathology , Inflammatory Bowel Diseases/prevention & control , /metabolism , /metabolism , Lipopolysaccharides/administration & dosage , Random Allocation , Rats, Wistar , Survival Analysis , Systemic Inflammatory Response Syndrome/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL